Application of interphase cytogenetics to monitor bone marrow transplants

Vickie Vrazas, Lisa M. Ooms, Christina Rudduck, Jeffrey Szer, Lynda J. Campbell, O. Margaret Garson

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Chromosomal in situ hybridization (ISH) has extended the scope of cytogenetic analysis to nondividing cells by the use of chromosome‐specific probes detected by nonisotopic techniques. This provides a rapid and sensitive method for identifying chromosomes in interphase cells, and is useful in gauging engraftment following bone marrow transplantation, particularly when the number of cells obtained is minimal. We have performed ISH using a Y‐heterochromatin‐specific probe to monitor patients with malignant hematological disease who have received a sex‐mismatched transplant. The results have been compared with those obtained from concurrently performed standard cytogenetic analysis. Host cells were detected by interphase cytogenetics in all patients posttransplant, at times varying from 28‐1,825 days, whereas routine analysis detected host cells in only 4 patients, 3 of whom were found to be in relapse. The significance of the persistence of host cells is unknown, but it does not appear to indicate impending relapse. © 1995 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)15-20
Number of pages6
JournalAmerican Journal of Hematology
Volume49
Issue number1
DOIs
Publication statusPublished - 1 Jan 1995
Externally publishedYes

Keywords

  • in situ hybridization
  • interphase cytogenetics
  • transplantation

Cite this